You are here

  • Home
  • Archive
  • Volume 105, Issue 5
  • APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration

Article metrics

Article menu
Download PDFPDF
Clinical science
APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 2020815264303
Jul 2020231312571242
Aug 2020393153
Sep 2020230105
Oct 2020188124
Nov 202023075
Dec 202019823
Jan 202122610
Feb 202124484
Mar 202122655
Apr 2021552139
May 20211562015
Jun 2021231917
Jul 20211794
Aug 2021151310
Sep 20211284
Oct 202116496
Nov 2021218124
Dec 202110764
Jan 202211783
Feb 20227932
Mar 202212552
Apr 2022170126
May 202216073
Jun 20229263
Jul 202216676
Aug 202218053
Sep 202210922
Oct 202211685
Nov 20229874
Dec 20225331
Jan 20238863
Feb 202318533
Mar 202313444
Apr 202310032
May 20238121
Jun 20234722
Jul 202313851
Aug 20235400
Sep 20235644
Oct 20234011
Nov 20238454
Dec 202317243
Jan 202410173
Feb 202410754
Mar 2024142125
Total932118261727